JPS60183032A - Emulsified composition - Google Patents
Emulsified compositionInfo
- Publication number
- JPS60183032A JPS60183032A JP59040080A JP4008084A JPS60183032A JP S60183032 A JPS60183032 A JP S60183032A JP 59040080 A JP59040080 A JP 59040080A JP 4008084 A JP4008084 A JP 4008084A JP S60183032 A JPS60183032 A JP S60183032A
- Authority
- JP
- Japan
- Prior art keywords
- water
- oil
- polyhydric alcohol
- protein
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 17
- 239000007764 o/w emulsion Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 23
- 229930186217 Glycolipid Natural products 0.000 abstract description 21
- 235000018102 proteins Nutrition 0.000 abstract description 21
- 239000003921 oil Substances 0.000 abstract description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract description 8
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 5
- 235000011187 glycerol Nutrition 0.000 abstract description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 abstract description 4
- 229940032094 squalane Drugs 0.000 abstract description 4
- 108010073771 Soybean Proteins Proteins 0.000 abstract description 3
- 239000004382 Amylase Substances 0.000 abstract description 2
- 102000013142 Amylases Human genes 0.000 abstract description 2
- 108010065511 Amylases Proteins 0.000 abstract description 2
- 102000008186 Collagen Human genes 0.000 abstract description 2
- 108010035532 Collagen Proteins 0.000 abstract description 2
- 108010068370 Glutens Proteins 0.000 abstract description 2
- 235000019418 amylase Nutrition 0.000 abstract description 2
- 229920001436 collagen Polymers 0.000 abstract description 2
- 229930195733 hydrocarbon Natural products 0.000 abstract description 2
- 150000002430 hydrocarbons Chemical class 0.000 abstract description 2
- 239000003760 tallow Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 235000021312 gluten Nutrition 0.000 abstract 1
- 229940001941 soy protein Drugs 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 14
- -1 fatty acid ester Chemical class 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- 235000015110 jellies Nutrition 0.000 description 5
- 239000008274 jelly Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- FROLUYNBHPUZQU-IIZJPUEISA-N (2R,3R,4S,5R)-2-(hydroxymethyl)-6-[3-[3-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropoxy]propoxy]oxane-3,4,5-triol Chemical compound OC[C@H]1OC(OCCCOCCCOC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O FROLUYNBHPUZQU-IIZJPUEISA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000002339 glycosphingolipids Chemical class 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010038061 Chymotrypsinogen Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- QUZHZFAQJATMCA-UHFFFAOYSA-N Monogalactosyldiglyceride Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCC=CCC)COC1OC(CO)C(O)C(O)C1O QUZHZFAQJATMCA-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 241001442654 Percnon planissimum Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000002270 gangliosides Chemical group 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は天然に存在し、最近免疫抗原として注して、化
粧品医薬品、食品などに有効に活用することを目的と1
−るものである。DETAILED DESCRIPTION OF THE INVENTION The present invention is a naturally occurring antigen, which has recently been used as an immunogenic antigen, and is intended to be effectively utilized in cosmetics, medicines, foods, etc.
-
近年、乳化に関する数多(の研究がなされ、多数の乳化
剤が開発され、また乳化技術の進歩もめざましく、非常
に安定なエマルジョンがあらゆる工業で広く利用されて
きている。しかし、その多くは、ポリオキシエチレン鎖
を含有する非イオン剤を乳化剤として使用しており、と
くに一般消費者の間で安全性に不安を抱くものが多い。In recent years, numerous studies have been conducted on emulsification, many emulsifiers have been developed, and advances in emulsification technology have been remarkable, and extremely stable emulsions have been widely used in all industries. A nonionic agent containing an oxyethylene chain is used as an emulsifier, and many general consumers in particular have concerns about safety.
研究した結果、糖脂質を多価アルコール中に溶解し、こ
れに油分を添加したならば、微細な粒子径を持つ安定性
良好なエマルジョンを製造し得ることを見いだした(特
願昭57−150353)。As a result of research, it was discovered that if glycolipids were dissolved in polyhydric alcohol and oil was added thereto, it was possible to produce emulsions with fine particle size and good stability (Japanese Patent Application No. 57-150353 ).
しかしながら糖脂質のみでは、乳化組成物の年分良好で
ない傾向があった。However, when using only glycolipids, there was a tendency that the results were not as good as those of emulsified compositions.
そこで本発明者等は鋭意研究した結果、糖脂質に蛋白質
を組み合〜已ごれらを多価アルコール中に溶解し、これ
に油分を添加したならば、得られた乳化組成物の粘度が
低くても、これに水を添加した場合、娼壬虫遭水中油型
乳化組成物は経口で良好な安定性を示すことを見いだし
、本発明を完成するに至った。Therefore, as a result of intensive research, the present inventors found that if a combination of protein and glycolipid was dissolved in polyhydric alcohol and an oil was added to this, the viscosity of the resulting emulsified composition could be reduced. The present inventors have discovered that an oil-in-water emulsion composition containing water, even at a low level, exhibits good oral stability when water is added thereto, leading to the completion of the present invention.
水酸基を有する水溶性多価アルコールと、油分とを含有
してなる乳化組成物、および○の乳化組成物をさらに水
と混合して得られる均一で微細な乳化粒子を有する安定
な水中油型乳化組成物を提(1するものである。An emulsion composition containing a water-soluble polyhydric alcohol having a hydroxyl group and an oil component, and a stable oil-in-water emulsion having uniform and fine emulsion particles obtained by further mixing the emulsion composition marked with ○ with water. A composition is provided.
本発明により得られた前記乳化組成物は透明もしくは半
透明の粘稠液体またはゲルであり、さらに水を加えた水
中油型乳化組成物は乳白色の微細粒子のエマルジョンで
ある。The emulsified composition obtained according to the present invention is a transparent or translucent viscous liquid or gel, and the oil-in-water emulsified composition obtained by adding water is an emulsion of milky white fine particles.
この微細粒子化の原因は、糖脂質と蛋白質が、多価アル
コール・油界面に効果的に配向し、相互作用をするため
と考えられる。The reason for this fine particle formation is thought to be that glycolipids and proteins are effectively oriented at the polyhydric alcohol/oil interface and interact with each other.
次に本発明の構成についてnlF述する。Next, the configuration of the present invention will be described.
本発明において用いられる水溶性多価゛アルコールは、
分子内に水酸基を2個以」二含有する水溶性多価アルコ
ールで、例エバ、エチレングリコール、プロピレングリ
コール、1.3−フチレンゲリコール、1.4−ブチレ
ングリコール、ジプロピレングリコール、グリセリン、
及びジグリセリン、トリグリセリン、テトラグリセリン
などのポリグリセリン、グルコース、マルトース、マル
チトール、蔗糖、フラクトース、キシリトール、ソルビ
トール、マルトトリオース
トール、澱粉分解糖還元アルコールなどでありこれらの
うち1種または2種以上が用いられる。 ゛配合量は糖
脂質と蛋白質と、多価アルコールと、油相とからなる乳
化組成物の2〜95重量%(以下、単に%と称ず)であ
る。The water-soluble polyhydric alcohol used in the present invention is
Water-soluble polyhydric alcohols containing two or more hydroxyl groups in the molecule, such as EVA, ethylene glycol, propylene glycol, 1,3-phthylene gelicol, 1,4-butylene glycol, dipropylene glycol, glycerin,
and polyglycerin such as diglycerin, triglycerin, and tetraglycerin, glucose, maltose, maltitol, sucrose, fructose, xylitol, sorbitol, maltotriostol, starch-degrading sugar-reducing alcohol, and one or two of these. The above is used. ``The blending amount is 2 to 95% by weight (hereinafter simply referred to as %) of the emulsified composition consisting of glycolipid, protein, polyhydric alcohol, and oil phase.
糖質を含む物質である。つまり、一般に、スフィンゴ糖
脂質、フィトグリコリピド、グリコジルグリセリFとし
て知られる糖脂質及びその他の糖脂質である。スフィン
ゴ糖脂質といては、モノへキソシルセラミト (セレブ
ロシド)、D−ガラクトシル− (1−4)’ーDーグ
ゝルコシルー (l−)セ等のジヘキソシルセラミド、
モノへキソシルセラミド脂肪酸エステルなどの中性オリ
ゴシルセラミド、ガラクトシルセラミF’硫酸エステル
などのスルファチド、D−ガラクトシルミル(1−・3
)−1)ーガラクトシル− (1→4)−〇ーガラクト
シルー (L.4)−D、−グルニノシル− (1−・
)セラミド(グI:]ボシドI)、I)−ガラクトジ・
ミル−(l→4)−D−ガラクトシル(1→4)−1)
−グルコシル−(1−=)セラミドなどのグロボシド、
N−アセチルノイラミン酸−12−3) Il−ガラク
トシル−(l→4)〜1〕ーグルコシルー (1−・)
セラミドなどのへマドシト、シアル酸÷ヘキソースアミ
ン+ヘギソ−ス+セラミ)−゛のガングリオシドである
。フィトグリコリピドとしてば、イノシトール+グルク
ロン酸+グルコザ鳳ン+ヘキソースを含むものである。It is a substance containing carbohydrates. namely, the glycolipids commonly known as glycosphingolipids, phytoglycolipids, glycosylglyceride F, and other glycolipids. Glycosphingolipids include monohexosylceramide (cerebroside), dihexosylceramide such as D-galactosyl-(1-4)'-D-galactosyl-(l-)ce,
Neutral oligosylceramides such as monohexosylceramide fatty acid ester, sulfatides such as galactosylcerami F' sulfate ester, D-galactosylmyl (1-, 3
)-1)-galactosyl- (1→4)-〇-galactosyl-(L.4)-D,-gulninosyl- (1-・
) ceramide (G I:]boside I), I)-galactodi-
Mil-(l→4)-D-galactosyl(1→4)-1)
- Globosides such as glucosyl-(1-=)ceramide,
N-acetylneuraminic acid-12-3) Il-galactosyl-(l→4)~1]-glucosyl-(1-・)
It is a ganglioside such as ceramide, sialic acid ÷ hexose amine + hexose + cerami). Examples of phytoglycolipids include inositol + glucuronic acid + glucosa chloride + hexose.
またグルコシルグリセリドとしてはモノガラク1ーシル
ジグリセリF,ジガラクトシルジグリセリド、ジガラク
トシルジグリセリドなどである。さらにその他の糖脂質
としては、とである。Examples of glucosylglycerides include monogalactyl diglyceride F, digalactosyl diglyceride, and digalactosyl diglyceride. Furthermore, other glycolipids include and.
上記物質の起源は、大豆、トウモロコシ、アマ、ラノカ
セイ、小麦等の種子に代表される高等植物から藻類、光
合成細菌にいたるまでの1」広い植物より得られる。ま
た、動物では特に、脳血液、精子等から1j′Iられ、
また、微生物においてはマイコバクテリア(MycQb
acteria) 、アリスロハクタ−(Arthob
actor ) 、シュードモナス(+’seudom
onas )ラクトパテラス(Lactobacill
us ) 、トルロプシス( Torulopsis)
など、広範囲の細菌、酵母より得られる。The above-mentioned substances are obtained from a wide variety of plants, ranging from higher plants such as seeds of soybeans, corn, flax, linseed, and wheat to algae and photosynthetic bacteria. In addition, in animals, 1j′I is especially obtained from cerebral blood, sperm, etc.
In addition, among microorganisms, mycobacteria (MycQb
acteria), Arthob
actor), Pseudomonas (+'seudom
onas ) Lactobacillus
us), Torulopsis
It can be obtained from a wide range of bacteria and yeast.
本発明で使用する蛋白質は、通品自然界より得られる蛋
白質であり、例えば、大豆蛋白、小麦蛋白、グルテリン
、ホエー粉末、大豆カゼイン、大豆粉、フィブロイン、
グルカゴン、二1ラーゲン、ゼラチン、エラスチン、卵
白リゾチーム、アミラーゼ、フィフ゛リノーゲン、ミオ
シン、コニノラーゼ、キモトリプシノーゲン、ヒストン
、アクチン、ケラチン、−・モグロビン、アビジン、ペ
プシン、グリアジン、生長ホルモン、アルブミン、グロ
ブリン、ミオグロビン、カゼイン、パパ、イン、β−ガ
ラクトソダーゼ、インソー1゜リン、リゾチ ム、カク
ラーセを挙げることができる。The proteins used in the present invention are proteins obtained from natural sources, such as soybean protein, wheat protein, glutelin, whey powder, soybean casein, soybean flour, fibroin,
Glucagon, 21lagen, gelatin, elastin, egg white lysozyme, amylase, fifirinogen, myosin, coninolase, chymotrypsinogen, histones, actin, keratin, moglobin, avidin, pepsin, gliadin, growth hormone, albumin, globulin, myoglobin, casein , papa, in, β-galactosodase, inso-1, lysothyme, and caclase.
前記の糖脂質と蛋白質を塩とし゛C使用する場合の塩を
形成する物質としては、リチウムイオン、ナトリウムイ
オン、カリウムイオン、セシウムイオン、アンモニウム
イオンを含む無機、有機塩基および塩基性無機、有機塩
、アルギニン、ヒスチジン、リジン、オルニチンなどの
塩基性アミノ酸およびそれらを残基として有する塩基性
オリゴペプチド、モノエタノールアミン、ジエノン −
ルアミン、トリエタノールアミン、アミノ糖などの塩基
性アミン等の塩基、及び、塩酸、硫酸、硝酸、炭酸など
の無機酸、酢酸、クエン酸、マレイン酸、フマール酸な
どの有機酸、グルタミン酸、アスパラギン酸などの酸性
アミノ酸及びそれらを残基として含むオリゴペプチド等
の酸が用いられる。When the above-mentioned glycolipids and proteins are used as salts, substances that form salts include inorganic and organic bases and basic inorganic and organic salts, including lithium ions, sodium ions, potassium ions, cesium ions, and ammonium ions; Basic amino acids such as arginine, histidine, lysine, ornithine, basic oligopeptides containing these as residues, monoethanolamine, dienones -
bases such as basic amines such as triamine, triethanolamine, and amino sugar; inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, and carbonic acid; organic acids such as acetic acid, citric acid, maleic acid, and fumaric acid; glutamic acid, and aspartic acid. Acidic amino acids such as and oligopeptides containing these as residues are used.
塩はあらかじめ反応さ・Uて塩にし一ζから添加しても
良いし、別々に添加して、乳化組成物の製造工程中で反
応させて塩にしてもよい。糖脂質と蛋白質の塩水溶液の
円1はいくつでも構わないが、できれば蛋白質の等電点
をさりることが好ましい。The salt may be reacted in advance to form a salt and added from the beginning, or may be added separately and reacted to form a salt during the manufacturing process of the emulsion composition. Any number of circles 1 of the salt aqueous solution of glycolipids and proteins may be used, but it is preferable that the isoelectric point of the protein be lowered if possible.
本発明においては、上記糖脂質と蛋白質の中から任意の
1種又は2種以上を選んで用いることができる。In the present invention, one or more of the above-mentioned glycolipids and proteins can be selected and used.
糖脂質と蛋白質の配合量は、重量比2:8〜8:2の範
囲で、それぞれ単独に使用した場合より飛躍的に良好な
乳化組成物が得られる。When the weight ratio of glycolipid and protein is in the range of 2:8 to 8:2, a significantly better emulsified composition can be obtained than when each is used alone.
糖脂質と蛋白質の総量と、多価アルコールの配合量は、
重量比でl:1〜1000の範囲である。多価アルコー
ルの配合量が糖脂質と蛋白質との総量に対し1未満であ
ると糖脂質と蛋白質の熔解性が悪くなり、1000を超
えると、乳化安定性が悪くなる。The total amount of glycolipids and proteins and the amount of polyhydric alcohol are as follows:
The weight ratio is in the range of l:1 to 1000. If the amount of polyhydric alcohol is less than 1 based on the total amount of glycolipids and proteins, the solubility of the glycolipids and proteins will be poor, and if it exceeds 1000, the emulsion stability will be poor.
本発明で用いられる油分は、牛脂、スクワラン、オリー
ブ油、コメヌカ油などの動植物油脂および炭化水素、流
動パラフィン、ワセリンなどの鉱物油、イソプロメビル
ミリステ−1−、ペンタエリスリトール−テトラ−2−
エチルヘキ号ノエー用・、ビタミンAバルミテ−1−、
ビタミンEアセテートなどのエステル油、メチルフェニ
ルシリコン、ジメチルシリコンなどのシリコン油等の、
化粧品、医薬品、食品等の業界で一般に利用される油分
である。本発明においCはこれらのうちから1種又は2
種以上が選ばれて用いられ、油分に対し、多価アルコー
ル、糖脂質並びに蛋白質との合計量が20%以上となる
ように調整することが望ましい。The oils used in the present invention include animal and vegetable oils and fats such as beef tallow, squalane, olive oil, and rice bran oil; hydrocarbons; mineral oils such as liquid paraffin and petrolatum; isopromevil myristate-1- and pentaerythritol-tetra-2-
For ethylhexane, vitamin A balmite 1-,
Ester oils such as vitamin E acetate, silicone oils such as methylphenyl silicone, dimethyl silicone, etc.
It is an oil commonly used in the cosmetics, pharmaceutical, food, and other industries. In the present invention, C is one or two of these.
It is desirable to select and use at least one type of oil and adjust the total amount of polyhydric alcohol, glycolipid, and protein to 20% or more of the oil content.
本発明に係る前記乳化組成物には前記の必須成分の他に
使用目的に合わせて、非イオン界面活性剤、アニオン界
面活性剤、カチオン界面活性剤、両性界面活性剤、薬剤
、紫外線吸収剤、防腐剤、酸化防止剤等を混合添加して
も良い。また、均質安定化、粘度調整の目的で、アルコ
ール、脂肪酸、他の水溶性高分子などを添加しても良い
。In addition to the above-mentioned essential components, the emulsified composition according to the present invention may include nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, drugs, ultraviolet absorbers, Preservatives, antioxidants, etc. may be mixed and added. Furthermore, alcohol, fatty acids, other water-soluble polymers, etc. may be added for the purpose of homogeneity stabilization and viscosity adjustment.
本発明の乳化組成物を得るには、多価アルコールまたは
その水溶液中に糖脂質と蛋白質を溶解し、攪拌しながら
油分を徐々添加することにより得られる。この場合、ホ
モミキサー処理を行うことが好ましいが、手攪拌等の弱
い攪拌力でも良好な乳化組成物を17ることができる。The emulsified composition of the present invention can be obtained by dissolving glycolipids and proteins in a polyhydric alcohol or an aqueous solution thereof, and gradually adding an oil component while stirring. In this case, it is preferable to perform a homomixer treatment, but a good emulsified composition can be prepared even with a weak stirring force such as manual stirring.
ここに得られた乳化組成物は、均一・で透明または半透
明のゲルまたは粘稠な液体であるのでこのままで、例え
ば、サンケアゼリー、美容液、食用ゼリー、薬用ゼリー
、マツサージゼリー、潤滑油などの化粧品、薬品、飼料
などあらゆる分野において使用することができる。The emulsified composition obtained here is a uniform, transparent or translucent gel or viscous liquid, so it can be used as is, such as sun care jelly, beauty serum, edible jelly, medicated jelly, pine surge jelly, lubricating oil, etc. It can be used in all fields such as cosmetics, medicine, and feed.
本発明に係る水中油型乳化組成物を得るには、前述した
乳化組成物と水とを混合すれば得られる。The oil-in-water emulsion composition according to the present invention can be obtained by mixing the above-described emulsion composition and water.
この場合、ホモミキサー処理を行うことが望ましい。こ
こに得られる水中油型乳化組成物は極めて安定性に優れ
たものである。In this case, it is desirable to perform homomixer treatment. The oil-in-water emulsion composition obtained here has extremely excellent stability.
水には、目的に応して湿潤剤、水溶性ビタミン、水溶性
防腐剤、水溶性薬剤、水溶性高分子など、化粧品、医薬
品、食品などの業界で一般に汎用されろ水相成分を添加
することもできる。Depending on the purpose, water phase components commonly used in the cosmetics, pharmaceutical, food, and other industries are added to the water, such as wetting agents, water-soluble vitamins, water-soluble preservatives, water-soluble drugs, and water-soluble polymers. You can also do that.
上記乳化組成物と水との量的関係については、極めて広
範囲に選択できるが、通常乳化組成物0.5〜80部に
対して水99.5〜20部である。The quantitative relationship between the emulsified composition and water can be selected from a very wide range, but is usually 99.5 to 20 parts of water to 0.5 to 80 parts of the emulsified composition.
ここに得られた水中油型乳化組成物は、均一な微細粒子
を分散した乳白色の粘稠あるいは低粘度の液体であるた
め、このままの形態でも乳液、クリーム、ファウンディ
ションなどの化粧品、シャンプー、リンスなどのトイレ
タリー製品、尿素クリーム、アクネクリームなどの医薬
品、マヨネーズなどの食品等あらゆる分野で好適に使用
することができる。また、均質安定化、粘性調整あるい
は薬効を持たせるために、他の水溶性高分子、薬剤、界
面活性剤、粉末、などを添加することも−・向に差支え
ない。The oil-in-water emulsion composition obtained here is a milky white viscous or low-viscosity liquid in which uniform fine particles are dispersed, so it can be used in cosmetics such as emulsions, creams, and foundations, shampoos, and conditioners even in its original form. It can be suitably used in various fields such as toiletry products such as urea cream, pharmaceutical products such as acne cream, and food products such as mayonnaise. In addition, other water-soluble polymers, drugs, surfactants, powders, etc. may be added to stabilize homogeneity, adjust viscosity, or impart medicinal effects.
以下、本発明を実施例及び比較例によっ゛(さらに詳細
に説明する。本発明はこれにより限定されるものではな
い。Hereinafter, the present invention will be explained in more detail with reference to Examples and Comparative Examples. The present invention is not limited thereto.
実施例1〜7、比較例1〜6
糖脂質、蛋白質、多価アルコール、精製水および油分を
表−1に示す配合組成及び量で配合し、70℃ホモミキ
サー処理して、乳化組成物を作った。さらに、この乳化
組成物に、それに対して10倍量の水を常温で攪拌しな
がら加えて、氷中浦型乳化化組成減物を作った。乳化組
成物と水中油型乳化組成物の 状態を観察し、特性値を
測定しそれらの結果を表−1に示した。なお、各成分の
数字は重量%である。Examples 1 to 7, Comparative Examples 1 to 6 Glycolipids, proteins, polyhydric alcohols, purified water, and oil components were blended in the composition and amounts shown in Table 1, and treated with a homomixer at 70°C to form an emulsified composition. Had made. Furthermore, 10 times the amount of water was added to this emulsified composition at room temperature while stirring to prepare a reduced ice Nakaura type emulsified composition. The conditions of the emulsified composition and oil-in-water emulsified composition were observed, and the characteristic values were measured, and the results are shown in Table 1. Note that the numbers for each component are weight %.
(以下余白)
表−1の(注−1)
水中油型乳化組成物状態は、1日放置後以下の基準にて
判定した。(Note 1 in Table 1) The condition of the oil-in-water emulsion composition was evaluated based on the following criteria after being left for one day.
■ 乳化粒子径1μ以下
Ol〜5μ
△ 5〜lOμ
x 10μ以上
表−2(注−2)
5 非常に良好
4 良好
3 やや良好
2 やや不良
1 非常に不良
表−1から明らかなように、糖脂質を乳化剤として単独
使用した場合(比較例1〜3.’6) 、その乳化組成
物の粘度はいずれも低く、更に水と混合して得られる水
中油型乳化組成物の1ケ月後の室温での安定性は良好で
はない。一方、蛋白質を乳化剤として単独で1使用した
場合(比較例4,5)粘度は高いが乳化粒子径は10μ
会以上であり、水中油型乳化組成物は分離した。これに
対して、本発明に係る実施例1〜7については、いずれ
の水準におい”ζも非常に良好な透明あるいは半透明の
粘稠な液体またはゲルが得られ、さらに、水を加えて得
られた水中油型乳化組成物は、非常に微細な粒子の分散
した安定なエマルジョンであった。■ Emulsified particle size 1μ or less Ol~5μ △ 5~lOμ x 10μ or more Table-2 (Note-2) 5 Very good 4 Good 3 Fairly good 2 Fairly poor 1 Very poor As is clear from Table-1, sugar When lipids were used alone as emulsifiers (Comparative Examples 1 to 3.'6), the viscosity of the emulsified compositions was low, and the viscosity of the oil-in-water emulsified composition obtained by mixing with water was lower than room temperature after one month. stability is not good. On the other hand, when protein is used alone as an emulsifier (Comparative Examples 4 and 5), the viscosity is high, but the emulsion particle size is 10 μm.
The oil-in-water emulsion composition was separated. On the other hand, in Examples 1 to 7 according to the present invention, transparent or translucent viscous liquids or gels with very good "ζ" values were obtained at all levels, and furthermore, they were obtained by adding water. The resulting oil-in-water emulsion composition was a stable emulsion in which very fine particles were dispersed.
実施例8 水性フェイシャルゼリー(重量%)(A)ラ
ムツリピッドR−12,0
カゼインナI・リウム 1.0
グリセリン 20,0
マルチトール(70%水溶液) 10.0ビタミンEア
セテート 0・5
防腐剤 0.5
香料 U
(A)相を70°c チー+−分攪拌し、(B)相を7
0℃で熔解したものを(Δ)相に攪拌しながら添加した
。このものをホモミキサー処理し、攪拌冷却して水性化
粧用油を得た。この化粧用油は、粘稠でやや流動感のあ
る透明ゲル状を呈し、皮膚安全性が高く、かつ経時安定
性の優れた乳化物で、皮INに塗布したとき、非常にの
びが良く、少量にて広範囲に拡がる使用特性を有してい
た。Example 8 Aqueous facial jelly (% by weight) (A) Lambtulipid R-12.0 Caseinna I.Rium 1.0 Glycerin 20.0 Maltitol (70% aqueous solution) 10.0 Vitamin E acetate 0.5 Preservative 0. 5 Fragrance U Stir the (A) phase at 70°C for 70°C, and stir the (B) phase at 70°C.
The mixture was melted at 0° C. and added to the (Δ) phase with stirring. This product was treated with a homomixer, stirred and cooled to obtain an aqueous cosmetic oil. This cosmetic oil has a viscous, slightly fluid, transparent gel-like appearance, and is an emulsion that is highly safe for the skin and has excellent stability over time.When applied to the skin, it spreads very well. It had properties that could be used over a wide range in small amounts.
実施例9 栄養乳液 (重量%)
(A>局方グリセリン 20.0
1.3−ブチレングリコール 5.0
大豆蛋白分IW物(分子量10000 ) 1.0水溶
性コラーゲン 1.0
イノシ1−−−ルグルクロン酸グルコサミンヘキソース
0・5
ジステアリルジグルコシルジグリセ
リ ド 1.0
アラン1−イン 0.2
水酸化ナトリウム 0.1
(B)スクワラン 10,0
ホボハ油 5.0
ペンタエリスリト−ルーテ1ラー
2−エチルヘキナノコニ−1−5,0
ワセリン 4.0
香料 0.3
(C)精製水 45.2
アルギン酸ナトリウム O11
キサンチンガム 0.1
実施例8の製造法に準じて、(A)相(B)相より乳化
組成物を得、70℃とし、別に調整し70“Cに保って
おいた増粘剤水溶液(C)相で希釈分散した後、冷却し
水中油型エマルジョンの栄養乳液を得た。この乳液の粘
度は30℃で、5600cpであり、乳化粒子径1〜3
μ程度の安定でかつなしみの良い感触を有していた。Example 9 Nutrient emulsion (% by weight) (A> Pharmacopoeia glycerin 20.0 1.3-butylene glycol 5.0 Soybean protein IW (molecular weight 10000) 1.0 Water-soluble collagen 1.0 Boar 1--- Glucosamine hexose luglucuronic acid 0.5 Distearyl diglucosyl diglyceride 1.0 Alane-1-yne 0.2 Sodium hydroxide 0.1 (B) Squalane 10.0 Joboha oil 5.0 Pentaerythritol-Rute 1-lar 2 -Ethylhequinanocony-1-5,0 Vaseline 4.0 Fragrance 0.3 (C) Purified water 45.2 Sodium alginate O11 Xanthine gum 0.1 According to the manufacturing method of Example 8, (A) phase ( An emulsion composition was obtained from phase B), heated to 70°C, diluted and dispersed with a thickener aqueous solution (phase C) prepared separately and maintained at 70°C, and then cooled to obtain a nutritional emulsion of an oil-in-water emulsion. The viscosity of this emulsion was 5,600 cp at 30°C, and the emulsion particle size was 1 to 3.
It had a stable feel of approximately μ and a smooth texture.
実施例1Oチンケアクリーム (重量シロ〉(A)ジグ
リセリン 20.0
ソJし)二1−−ル(70%水’/41皮)8,0果2
1!7(50%水溶液)2.O
シバルミ1−イルモノガラクトシル
ジグリセリド 0.5
フラクト−スリピノF’ 3.0
力セインナトリウム 0.5
(13)スクワラン 21.5
イソゾロビルミリステー ト 10.0ソヒリン 5.
0
ステアリルアルコール 5.0
))ΔB A 2.0
防腐剤 0.5
香料 ()、G
lf、5
(C)精製水 月辷半−
ヒト′篭二rキンエチルセル
(1))調合粉末 1.0
二酸化チタン 2.0
実施例8の製造法にtl@ シて、チンケアクリームを
得た。このとき、(C)相は(D)相を70°Cにて分
散ホモミキ9′−処理した後、霜釈相として使用した。Example 1 O Chin Care Cream (Weight: (A) Diglycerin 20.0 Soj) 21--L (70% Water'/41 Peel) 8.0 Fruit 2
1!7 (50% aqueous solution)2. O Sibalmyl 1-yl monogalactosyl diglyceride 0.5 Fructo-Slipino F' 3.0 Sodium ceine 0.5 (13) Squalane 21.5 Isozolobyl myristate 10.0 Sohiline 5.
0 Stearyl alcohol 5.0 )) ΔB A 2.0 Preservative 0.5 Fragrance (), Glf, 5 (C) Purified water Human's quince ethyl cell (1)) Mixed powder 1.0 Titanium dioxide 2.0 A tin care cream was obtained by following the manufacturing method of Example 8. At this time, the (C) phase was used as a frosting phase after dispersing and homomixing the (D) phase at 70°C.
このチンケアクリームは、25゛Cで硬度が26であり
、やや透明感がありーまた乳化粒子径が1〜3μ程度で
安定性の良い水中油型乳化組成物で、太陽光の下で好適
に使用できるものであった。This chin care cream has a hardness of 26 at 25°C, is slightly transparent, and has a stable oil-in-water emulsion composition with an emulsion particle size of about 1 to 3μ, making it suitable for use under sunlight. It could be used for.
特許出願人 株式会社 資 生 堂Patent applicant: Shiseido Co., Ltd.
Claims (1)
2種以上と蛋白質および/またはその塩の1種または2
種以上と、分子内に2個以上の水酸基を有する水溶性多
価アルコールと、油分とを含有することを特徴とする乳
化組成物。 することを特徴とする水中油型乳化組成物。[Claims] +11 11i One or more types of lipid and/or its salt and one or more types of protein and/or its salt
1. An emulsified composition comprising: a water-soluble polyhydric alcohol having two or more hydroxyl groups in the molecule; and an oil component. An oil-in-water emulsion composition characterized by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59040080A JPS60183032A (en) | 1984-03-02 | 1984-03-02 | Emulsified composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59040080A JPS60183032A (en) | 1984-03-02 | 1984-03-02 | Emulsified composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60183032A true JPS60183032A (en) | 1985-09-18 |
| JPH057061B2 JPH057061B2 (en) | 1993-01-28 |
Family
ID=12570925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59040080A Granted JPS60183032A (en) | 1984-03-02 | 1984-03-02 | Emulsified composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60183032A (en) |
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61260008A (en) * | 1985-05-15 | 1986-11-18 | Sunstar Inc | Cosmetic composition |
| BE1005704A4 (en) * | 1992-02-04 | 1993-12-21 | Piljac Goran & Piljac Visnja | Rhamnolipid based pharmaceutical preparation |
| US5455232A (en) * | 1992-02-04 | 1995-10-03 | Piljac; Goran | Pharmaceutical preparation based on rhamnolipid |
| JP2008118983A (en) * | 2006-10-17 | 2008-05-29 | Idemitsu Kosan Co Ltd | Feed additives and feed |
| JP2009005676A (en) * | 2007-05-31 | 2009-01-15 | Idemitsu Kosan Co Ltd | Feed additive for ruminants and feed containing the same |
| WO2013098066A2 (en) | 2011-12-28 | 2013-07-04 | Evonik Industries Ag | Aqueous hair and skin cleaning compositions comprising biotensides |
| DE102013206314A1 (en) | 2013-04-10 | 2014-10-16 | Evonik Industries Ag | Cosmetic formulation containing copolymer as well as sulfosuccinate and / or biosurfactant |
| EP3070155A1 (en) | 2015-03-18 | 2016-09-21 | Evonik Degussa GmbH | Composition comprising peptidase and biosurfactant |
| WO2016207203A1 (en) | 2015-06-25 | 2016-12-29 | Basf Se | Additive for alkaline zinc plating |
| EP3290020A1 (en) | 2016-08-29 | 2018-03-07 | Richli, Remo | Mild preparations containing alkoxylated fatty acid amides |
| EP3290501A1 (en) | 2016-08-29 | 2018-03-07 | Richli, Remo | Detergent compositions containing alkoxylated fatty acid amides |
| EP3290500A1 (en) | 2016-08-29 | 2018-03-07 | Richli, Remo | Detergent composition and care composition containing polyoxyalkylene carboxylate |
| WO2018145966A1 (en) | 2017-02-10 | 2018-08-16 | Evonik Degussa Gmbh | Oral care composition containing at least one biosurfactant and fluoride |
| WO2018197623A1 (en) | 2017-04-27 | 2018-11-01 | Evonik Degussa Gmbh | Biodegradable cleaning composition |
| WO2019214968A1 (en) | 2018-05-11 | 2019-11-14 | Basf Se | Detergent composition comprising rhamnolipids and/or mannosylerythritol lipids |
| CN114929191A (en) * | 2019-10-18 | 2022-08-19 | 德西姆美容集团公司 | Skin care formulations with lipophilins |
| US11591547B2 (en) | 2017-04-27 | 2023-02-28 | Evonik Operations Gmbh | Biodegradable cleaning composition |
| EP4234671A1 (en) | 2022-02-24 | 2023-08-30 | Evonik Operations GmbH | Compositions containing biosurfactants and a lipase from stachybotrys chlorohalonata |
| WO2023161179A1 (en) | 2022-02-24 | 2023-08-31 | Evonik Operations Gmbh | New composition containing liposomes and biosurfactants |
| EP4269531A1 (en) | 2022-04-28 | 2023-11-01 | Evonik Operations GmbH | Multifunctional wax dispersant for subterranean chemical applications |
| EP4269530A1 (en) | 2022-04-28 | 2023-11-01 | Evonik Operations GmbH | Multifunctional wax dispersant for subterranean chemical applications |
| WO2024002738A1 (en) | 2022-06-28 | 2024-01-04 | Evonik Operations Gmbh | Composition comprising biosurfactant and persicomycin |
| EP4361238A1 (en) | 2022-10-26 | 2024-05-01 | ChemTEK UG (haftungsbeschränkt) | Compositions comprising glycamines |
| WO2024115213A1 (en) | 2022-11-30 | 2024-06-06 | Evonik Operations Gmbh | Detergent compartment pouch comprising biosurfactants |
| EP4382090A1 (en) | 2022-12-08 | 2024-06-12 | Evonik Operations GmbH | Cosmetical and pharmaceutical compositions containing bacillus strains or fermentation broths thereof |
| WO2024132679A1 (en) | 2022-12-21 | 2024-06-27 | Evonik Dr. Straetmans Gmbh | Compositions containing biosurfactants and desferrioxamines |
| WO2025137028A1 (en) | 2023-12-18 | 2025-06-26 | L'oreal | Cosmetic emulsion comprising hydrophobic polymer |
| WO2025137065A1 (en) | 2023-12-18 | 2025-06-26 | L'oreal | Cleansing wipe comprising hydrophobic polymer |
| WO2025137014A1 (en) | 2023-12-18 | 2025-06-26 | L'oreal | Mineral sunscreen and pigment dispersion comprising hydrophobic polymer |
| FR3159328A3 (en) | 2024-02-21 | 2025-08-22 | L'oreal | Cleaning wipe containing a hydrophobic polymer |
| FR3159520A3 (en) | 2024-02-26 | 2025-08-29 | L'oreal | Cosmetic emulsion comprising a hydrophobic polymer |
| FR3159525A3 (en) | 2024-02-27 | 2025-08-29 | L'oreal | mineral sunscreen composition COMPRISING A HYDROPHOBIC POLYMER |
| FR3159521A3 (en) | 2024-02-26 | 2025-08-29 | L'oreal | Oil-in-water dispersion comprising |
| FR3159518A3 (en) | 2024-02-26 | 2025-08-29 | L'oreal | Cosmetic composition comprising a skin active agent |
| FR3159896A3 (en) | 2024-03-06 | 2025-09-12 | L'oreal | PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60163806A (en) * | 1984-02-03 | 1985-08-26 | Pola Chem Ind Inc | Skin pharmaceutical for external use |
-
1984
- 1984-03-02 JP JP59040080A patent/JPS60183032A/en active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60163806A (en) * | 1984-02-03 | 1985-08-26 | Pola Chem Ind Inc | Skin pharmaceutical for external use |
Cited By (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61260008A (en) * | 1985-05-15 | 1986-11-18 | Sunstar Inc | Cosmetic composition |
| BE1005704A4 (en) * | 1992-02-04 | 1993-12-21 | Piljac Goran & Piljac Visnja | Rhamnolipid based pharmaceutical preparation |
| US5455232A (en) * | 1992-02-04 | 1995-10-03 | Piljac; Goran | Pharmaceutical preparation based on rhamnolipid |
| JP2008118983A (en) * | 2006-10-17 | 2008-05-29 | Idemitsu Kosan Co Ltd | Feed additives and feed |
| JP2009005676A (en) * | 2007-05-31 | 2009-01-15 | Idemitsu Kosan Co Ltd | Feed additive for ruminants and feed containing the same |
| WO2013098066A2 (en) | 2011-12-28 | 2013-07-04 | Evonik Industries Ag | Aqueous hair and skin cleaning compositions comprising biotensides |
| DE102011090030A1 (en) | 2011-12-28 | 2013-07-04 | Evonik Industries Ag | Aqueous hair and skin cleansing compositions containing biosurfactants |
| US9271908B2 (en) | 2011-12-28 | 2016-03-01 | Evonik Industries Ag | Aqueous hair and skin cleaning compositions comprising biotensides |
| DE102013206314A1 (en) | 2013-04-10 | 2014-10-16 | Evonik Industries Ag | Cosmetic formulation containing copolymer as well as sulfosuccinate and / or biosurfactant |
| WO2016146497A1 (en) | 2015-03-18 | 2016-09-22 | Evonik Degussa Gmbh | Composition containing peptidase and biosurfactant |
| EP3070155A1 (en) | 2015-03-18 | 2016-09-21 | Evonik Degussa GmbH | Composition comprising peptidase and biosurfactant |
| EP3907272A1 (en) | 2015-03-18 | 2021-11-10 | Evonik Operations GmbH | Composition comprising peptidase and biosurfactant |
| WO2016207203A1 (en) | 2015-06-25 | 2016-12-29 | Basf Se | Additive for alkaline zinc plating |
| US10718060B2 (en) | 2015-06-25 | 2020-07-21 | Basf Se | Additive for alkaline zinc plating |
| EP3998059A1 (en) | 2016-08-29 | 2022-05-18 | Perfect Ideas GmbH | Mild preparations as cleaning or care compositions for removing carbohydrates or stains |
| EP3290020A1 (en) | 2016-08-29 | 2018-03-07 | Richli, Remo | Mild preparations containing alkoxylated fatty acid amides |
| EP3290501A1 (en) | 2016-08-29 | 2018-03-07 | Richli, Remo | Detergent compositions containing alkoxylated fatty acid amides |
| EP3290500A1 (en) | 2016-08-29 | 2018-03-07 | Richli, Remo | Detergent composition and care composition containing polyoxyalkylene carboxylate |
| WO2018145966A1 (en) | 2017-02-10 | 2018-08-16 | Evonik Degussa Gmbh | Oral care composition containing at least one biosurfactant and fluoride |
| US11464717B2 (en) | 2017-02-10 | 2022-10-11 | Evonik Operations Gmbh | Oral care composition containing at least one biosurfactant and fluoride |
| US11591547B2 (en) | 2017-04-27 | 2023-02-28 | Evonik Operations Gmbh | Biodegradable cleaning composition |
| WO2018197623A1 (en) | 2017-04-27 | 2018-11-01 | Evonik Degussa Gmbh | Biodegradable cleaning composition |
| US11746307B2 (en) | 2017-04-27 | 2023-09-05 | Evonik Operations Gmbh | Biodegradable cleaning composition |
| WO2019214968A1 (en) | 2018-05-11 | 2019-11-14 | Basf Se | Detergent composition comprising rhamnolipids and/or mannosylerythritol lipids |
| JP2024156049A (en) * | 2019-10-18 | 2024-10-31 | デシエム ビューティー グループ インコーポレイテッド | Skin care formulations using lipophilic peptides |
| JP2022552578A (en) * | 2019-10-18 | 2022-12-16 | デシエム ビューティー グループ インコーポレイテッド | Skin care formulations using lipophilic peptides |
| CN114929191A (en) * | 2019-10-18 | 2022-08-19 | 德西姆美容集团公司 | Skin care formulations with lipophilins |
| EP4234671A1 (en) | 2022-02-24 | 2023-08-30 | Evonik Operations GmbH | Compositions containing biosurfactants and a lipase from stachybotrys chlorohalonata |
| WO2023161179A1 (en) | 2022-02-24 | 2023-08-31 | Evonik Operations Gmbh | New composition containing liposomes and biosurfactants |
| EP4269530A1 (en) | 2022-04-28 | 2023-11-01 | Evonik Operations GmbH | Multifunctional wax dispersant for subterranean chemical applications |
| US11999901B2 (en) | 2022-04-28 | 2024-06-04 | Evonik Operations Gmbh | Multifunctional wax dispersant for subterranean chemical applications |
| US12454641B2 (en) | 2022-04-28 | 2025-10-28 | Evonik Operations Gmbh | Multifunctional wax dispersant for subterranean chemical applications |
| EP4269531A1 (en) | 2022-04-28 | 2023-11-01 | Evonik Operations GmbH | Multifunctional wax dispersant for subterranean chemical applications |
| WO2024002738A1 (en) | 2022-06-28 | 2024-01-04 | Evonik Operations Gmbh | Composition comprising biosurfactant and persicomycin |
| US12448588B2 (en) | 2022-06-28 | 2025-10-21 | Evonik Operations Gmbh | Composition comprising biosurfactant and persicomycin (3-(3′hydroxy)hydroxy fatty acid) |
| EP4361238A1 (en) | 2022-10-26 | 2024-05-01 | ChemTEK UG (haftungsbeschränkt) | Compositions comprising glycamines |
| WO2024115213A1 (en) | 2022-11-30 | 2024-06-06 | Evonik Operations Gmbh | Detergent compartment pouch comprising biosurfactants |
| WO2024120910A1 (en) | 2022-12-08 | 2024-06-13 | Evonik Operations Gmbh | Cosmetical and pharmaceutical compositions containing bacillus strains or fermentation broths thereof |
| EP4382090A1 (en) | 2022-12-08 | 2024-06-12 | Evonik Operations GmbH | Cosmetical and pharmaceutical compositions containing bacillus strains or fermentation broths thereof |
| WO2024132679A1 (en) | 2022-12-21 | 2024-06-27 | Evonik Dr. Straetmans Gmbh | Compositions containing biosurfactants and desferrioxamines |
| WO2025137028A1 (en) | 2023-12-18 | 2025-06-26 | L'oreal | Cosmetic emulsion comprising hydrophobic polymer |
| WO2025137065A1 (en) | 2023-12-18 | 2025-06-26 | L'oreal | Cleansing wipe comprising hydrophobic polymer |
| WO2025137014A1 (en) | 2023-12-18 | 2025-06-26 | L'oreal | Mineral sunscreen and pigment dispersion comprising hydrophobic polymer |
| FR3159328A3 (en) | 2024-02-21 | 2025-08-22 | L'oreal | Cleaning wipe containing a hydrophobic polymer |
| FR3159520A3 (en) | 2024-02-26 | 2025-08-29 | L'oreal | Cosmetic emulsion comprising a hydrophobic polymer |
| FR3159521A3 (en) | 2024-02-26 | 2025-08-29 | L'oreal | Oil-in-water dispersion comprising |
| FR3159518A3 (en) | 2024-02-26 | 2025-08-29 | L'oreal | Cosmetic composition comprising a skin active agent |
| FR3159525A3 (en) | 2024-02-27 | 2025-08-29 | L'oreal | mineral sunscreen composition COMPRISING A HYDROPHOBIC POLYMER |
| FR3159896A3 (en) | 2024-03-06 | 2025-09-12 | L'oreal | PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH057061B2 (en) | 1993-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS60183032A (en) | Emulsified composition | |
| JPH0230733B2 (en) | ||
| CN111643376A (en) | Nano-emulsion composition and application thereof | |
| KR101116899B1 (en) | Concentrated and diluted stable oil/water emulsions | |
| EP2617410B1 (en) | Oil-in-water type cosmetic | |
| JPH0356777B2 (en) | ||
| JPH0364185B2 (en) | ||
| JPH078333B2 (en) | Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition | |
| JP2944258B2 (en) | Emulsion type cosmetic | |
| JPS5939338A (en) | Emulsified composition | |
| JPS59139310A (en) | Emulsified composition | |
| JPH0435211B2 (en) | ||
| JPS58183938A (en) | Emulsified composition | |
| JPS5998727A (en) | Emulsified composition | |
| JPH0435212B2 (en) | ||
| JPH0710338B2 (en) | Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition | |
| JPS61204109A (en) | Emulsion-type composition for external use | |
| JPS5926130A (en) | Emulsion composition | |
| JPS5920212A (en) | Emulsified composition | |
| JPS60244335A (en) | Emulsified composition | |
| JPH045490B2 (en) | ||
| JPH0720543B2 (en) | Method for producing gel emulsion and oil-in-water emulsion | |
| JPS6097043A (en) | Emulsified composition | |
| JPS59173124A (en) | Emulsified composition | |
| JPS59173125A (en) | Emulsified composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |